Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson’s disease in an autosomal dominant manner
LRRK2 (leucine-rich repeat kinase 2) has been identified as agene corresponding to PARK8, an autosomal-dominant genefor familial Parkinson’s disease (PD). LRRK2 pathogenicspecificmutants induce neurotoxicity and shorten neurites. Toelucidate the mechanism underlying LRRK2 expression, weconstructed t...
Main Authors: | Ji-Min Park, Dong-Hwan Ho, Hye Jin Yun, Hye-Jung Kim, Chan Hong Lee, Sung Woo Park, Young Hoon Kim, Ilhong Son, Wongi Seol |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society for Biochemistry and Molecular Biology
2013-09-01
|
Series: | BMB Reports |
Subjects: | |
Online Access: | http://bmbreports.org/jbmb/pdf.php?data=MTMxMDA3MTZAcGRmX3JhaW50cmFjZV9sZWV5c0AlNUI0Ni05JTVEMTMwOTI2MTcyN18lMjg0NTQtNDU5JTI5Qk1CXzEyLTIzNC5wZGY= |
Similar Items
-
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
by: Dong-Hwan Ho, et al.
Published: (2022-03-01) -
G2019s LRRK2 promotes mitochondrial fission and increases TNFα-mediated neuroinflammation responses
by: Dong Hwan Ho, et al.
Published: (2019-03-01) -
Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
by: Daleum Nam, et al.
Published: (2021-01-01) -
LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?
by: Darren M. O’Hara, et al.
Published: (2020-06-01) -
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
by: Michael X. Henderson, et al.
Published: (2018-05-01)